CONMED Corp — Director's Dealing 2019

Aug 6, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2019-08-01

Reporting Person: Kuyper Dirk (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-02	Common Stock	M	5396	$41.06	Acquired	10396	Direct
2019-08-02	Common Stock	S	5396	$91.10	Disposed	5000	Direct
2019-08-02	Common Stock	M	3669	$51.90	Acquired	8669	Direct
2019-08-02	Common Stock	S	3669	$91.04	Disposed	5000	Direct
2019-08-02	Common Stock	M	2549	$69.03	Acquired	7549	Direct
2019-08-02	Common Stock	S	2549	$91.17	Disposed	5000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-08-01	Options To Purchase Common Stock	$79.94	D	2165	Disposed	2029-06-03	Common Stock (2165)	Direct
2019-08-01	Rsus (restricted Stock Units)	$0	D	1407	Disposed	2029-06-03	Common Stock (1407)	Direct
2019-08-02	Options To Purchase Common Stock	$41.06	M	5396	Disposed	2026-06-01	Common Stock (5396)	Direct
2019-08-02	Options To Purchase Common Stock	$51.90	M	3669	Disposed	2027-06-01	Common Stock (3669)	Direct
2019-08-02	Options To Purchase Common Stock	$69.03	M	2549	Disposed	2028-06-01	Common Stock (2549)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.00 to $91.68. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.00 to $91.19. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.00 to $91.33. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F4: The stock options expired without vesting as a consequence of Mr. Kuyper's resignation from the Board prior to the completion of the 2019 term of service.

F5: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.

F6: The RSUs expired without vesting as a consequence of Mr. Kuyper's resignation from the Board prior to the completion of the 2019 term of service.

F7: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.